San Diego, CA, United States of America

Jianing Wang

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 99(Granted Patents)


Location History:

  • Murrieta, CA (US) (2015)
  • San Diego, CA (US) (2017 - 2022)
  • La Jolla, CA (US) (2014 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Jianing Wang in Antibody Drug Conjugates

Introduction

Jianing Wang is a prominent inventor based in San Diego, CA, known for her pioneering contributions in the field of antibody drug conjugates. With a remarkable portfolio of eight patents, she has made significant strides in addressing complex medical challenges, particularly in cancer treatment and inflammation.

Latest Patents

Among her latest inventions is the development of humanized anti-prostate-specific membrane antigen (PSMA) antibody drug conjugates. This invention relates to humanized antibodies targeting PSMA and the accompanying antibody drug conjugates. It involves methods and compositions that focus on inhibiting, preventing, or treating PSMA-related diseases or cancers. Additionally, she has innovated an antibody drug conjugate for anti-inflammatory applications. This technology comprises an antibody conjugated to an anti-inflammatory therapeutic agent via a phosphate-based linker, which offers tunable extracellular and intracellular stability, showcasing her versatility in therapeutic applications.

Career Highlights

Throughout her career, Jianing has worked with reputable organizations, including the University of Georgia Research Foundation, Inc. and Ambrx, Inc. Her work has not only advanced scientific understanding but has also held the potential for impactful clinical applications.

Collaborations

In her innovative journey, Jianing has collaborated with esteemed professionals, including Chung K. Chu and Robert M. Garbaccio. These partnerships highlight the collaborative spirit prevalent in research and innovation, further enhancing the quality and depth of her work.

Conclusion

Jianing Wang continues to be a leading force in the development of novel antibody drug conjugates. Her contributions, particularly in anti-PSMA therapies and anti-inflammatory applications, demonstrate her commitment to improving health outcomes through innovative solutions. Her patents reflect her expertise and dedication to advancing medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…